<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03505398</url>
  </required_header>
  <id_info>
    <org_study_id>RC17_0134</org_study_id>
    <secondary_id>2017-A00977-46</secondary_id>
    <nct_id>NCT03505398</nct_id>
  </id_info>
  <brief_title>Study of Visual-spatial Attention by Eye Tracking as a Function of Central or Peripheral Visual Impairment</brief_title>
  <acronym>BEHAVE</acronym>
  <official_title>Study of Visual-spatial Attention by Oculomotor Recording (Eye Tracking) as a Function of Central or Peripheral Visual Impairment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this pilot work is to determine the role of central and peripheral visions
      in explicit attention processes (saccade planning) in the case of visual impairment.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2018</start_date>
  <completion_date type="Anticipated">April 2020</completion_date>
  <primary_completion_date type="Anticipated">April 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of visual acuity (central versus peripheral)</measure>
    <time_frame>Day 0</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Microperimetry recording (central versus peripheral)</measure>
    <time_frame>Day 0</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>recording of automated visual field (central versus peripheral)</measure>
    <time_frame>Day 0</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>recording of eye movements (central versus peripheral)</measure>
    <time_frame>Day 0</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Measurement of visual acuity (patient versus control)</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Microperimetry recording (patient versus control)</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>recording of automated visual field (patient versus control)</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>recording of eye movements (patient versus control)</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Central or Peripheral Visual Impairment</condition>
  <arm_group>
    <arm_group_label>central vision disorder</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>peripheral vision disorder</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>microperimetry</intervention_name>
    <description>define the retinal fixation point and the differential sensitivity threshold of the retina.</description>
    <arm_group_label>central vision disorder</arm_group_label>
    <arm_group_label>peripheral vision disorder</arm_group_label>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>visual acuity</intervention_name>
    <description>using ETDRS scales</description>
    <arm_group_label>central vision disorder</arm_group_label>
    <arm_group_label>peripheral vision disorder</arm_group_label>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>automated visual field</intervention_name>
    <description>recording visual attention based on central or peripheral visual information</description>
    <arm_group_label>central vision disorder</arm_group_label>
    <arm_group_label>peripheral vision disorder</arm_group_label>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>eye movements recording</intervention_name>
    <description>recording of explicit visual attention based on central or peripheral visual information</description>
    <arm_group_label>central vision disorder</arm_group_label>
    <arm_group_label>peripheral vision disorder</arm_group_label>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female ≥18 years;

          -  Patient with a central visual deficit (central scotoma on the visual field: DMLA,
             cones dystrophy ...) or peripheral (annular scotoma: chronic glaucoma, retinitis
             pigmentosa ...) or without visual deficit (corrected visual acuity and visual field)

          -  Patient agreeing to participate in the study and signing informed consent

          -  Patient affiliated to social security

        Exclusion Criteria:

          -  Pregnant woman

          -  Patient with known epilepsy

          -  Major under judicial safeguard, or deprived of liberty

          -  Major under guardianship or curatorship or admitted to a health or social institution
             for purposes other than research.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Guylène Le Meur, Pr</last_name>
    <phone>33 (0) 2 44 76 82 87</phone>
    <email>guylene.lemeur@chu-nantes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pierre Lebranchu, Dr</last_name>
    <email>pierre.lebranchu@chu-nantes.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pierre Lebranchu, Dr</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 27, 2018</study_first_submitted>
  <study_first_submitted_qc>April 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 23, 2018</study_first_posted>
  <last_update_submitted>April 20, 2018</last_update_submitted>
  <last_update_submitted_qc>April 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vision Disorders</mesh_term>
    <mesh_term>Vision, Low</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

